skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review

Review

(10625) Views  (1125) Full article downloads

Authors: Steve Fordan, Philip Raskin

Published Date February 2009 Volume 2009:5 Pages 225 - 231
DOI: http://dx.doi.org/10.2147/VHRM.S3402

Steve Fordan, Philip Raskin

Department of Medicine, Division, of Endocrinology, University of Texas, Southwestern Medical Center, Dallas, TX, USA

Abstract: The insulin analogs lispro, aspart, and glulisine are the only commercially available rapid-acting insulins to treat diabetes. We review the evidence for treating hyperglycemia, using insulin, and specifically using rapid-acting analogs in diabetic individuals, on the prevention of vascular events. We review the beneficial effects of insulin on the vascular system, which include vasodilation and anti-inflammatory actions. The effects of treating hyperglycemia and intensive blood glucose control on vascular outcomes are reviewed.

Keywords: lispro, aspart, glulisine, nitric oxide synthetase, nuclear factor kappa B

 








Readers of this article also read:

Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
The western diet and lifestyle and diseases of civilization
Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study
Use of carvedilol in hypertension: an update
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University